Prof. Marks: How to commercialize research and development? Insights from Biotech and healthcare

Apr 3, 2018, 10:30 AM – 1:00 PM

Startupbootcamp Innovation Space, Thinkzone, Building 10, Level 9, Chengdu, 610000

For our 15th Startup Grind Chengdu we will invite Robert Marks, a professor, serial entrepreneur and biosensor expert. Prof. Robert Marks has dedicated his career to research and development of novel biosensor technologies in areas ranging from medical diagnostics, water safety, environmental monitoring, basic research and more.

In-person event

About this event

The fireside chat will discuss topics like:

1. Understanding of biotech industry, industry trends, application of biotech into our daily lives.

2. What are the differences of technology environment among Israel, Singapore, China and the US? 

3. How to commercialize research and development? 

4. How to deal globally with governments, universities and business relations? 


Prof. Dr. Robert S. Marks is a renowned expert and key opinion leader in the field of biosensors. He is a Full Professor at the Ben-Gurion University of the Negev, Israel, at the Department of Biotechnology Engineering. He is presently a Visiting Scientist at the DxD hub at Astar in Singapore.

Robert has previously co-founded Biosensing Technologies Ltd, Biopixel Ltd and Polyrizon Ltd as well as P@bbles whose mission is to introduce new Israeli ventures into Asia.

He is the Editor-in-Chief of a 2007 2-volume Wiley Handbook in Biosensors and Biochips and a 2014 Viral Diagnostics book for virus detection among other books. He also author of 150+ papers (H-index 27) and has several issued patents as well as a dozen filed.

His startups:

Biosensorix and Eclipse DX aim to provide accurate and convenient diagnostic solutions for rural and urban doctors to save life and save medical costs.

It has developed an point-of-care diagnostic tool that is cheap and easy to use. It can not only be used repeatedly, but also provide quantitative and accurate diagnostic results. In 2016, the global point-of-care diagnostics market was valued at about 19.3 billion US dollars, and Biosensorix aims to account for 8.7 billion of the market. Compared with competitors, their products are affordable, portable and easy to use and can provide quantitative detection. 

Check out what happened


  • Prof. Robert Marks





Tuesday, April 3, 2018
10:30 AM – 1:00 PM UTC


Intro & Startup Rallye
Fireside Chat


  • Xuemei Zhong

    Easygo business consulting

    Chapter Director

About Startup Grind

This is Startup Grind. We are the world’s largest startup community.

Our Mission

To give startups everywhere the education and opportunities they need to build, grow, and scale their companies.

Our Values

We believe in making friends, not contacts. We believe in giving first, not taking. We believe in helping others before helping yourself.

Tools & Discounts for Startups

Take advantage of resources and offers provided by organizations we know and love, designed to help you navigate the startup journey.

Global Conference

Our annual flagship event in Silicon Valley brings together thousands of startup teams, investors and organizations from all over the world.

Join the Startup Membership

This membership gives you free access to networking, events, mentorship, office hours, and other exclusive opportunities curated by Startup Grind HQ.